Emelia J. Benjamin, MD, ScM, FACC, FAHA, received her undergraduate degree at Harvard, her MD at Case Western Reserve University, and her Master’s in Epidemiology at Harvard School of Public Health. She is a Professor of Medicine and Epidemiology at Boston University and is a clinical cardiologist at Boston Medical Center. She is author of over 600 peer-reviewed publications that focus on the on the genetics, epidemiology, and prognosis of a variety of cardiovascular conditions and markers including atrial fibrillation, vascular function, and systemic inflammation. She is multi-Principal Investigator on 2RO1 grants [2R01HL092577 & 1R01HL128914]. Her grants examine the epidemiology, outcomes, and genetics of atrial fibrillation.
Dr. Benjamin has conducted research at the Framingham Study since 1988. She is a Member of the Executive Committee, and is Co-Director of the Medical Endpoints Committee. She is Principal Investigator of the grant that recruited the second generation of the Framingham Study’s ethnic/racial minority cohort, the Omni Study.
In addition to her research, she is Assistant Provost for Faculty Development for Boston University Medical Campus, and Vice Chair for Faculty Development and Diversity, BU Department of Medicine. She co-designed and co-leads Early, Mid-Career, Under-Represented Ethnic and Racial group, and Women’s Faculty leadership programs. A committed mentor, she has won local and national awards for her mentoring of early career investigators.
An active volunteer for the American Heart Association since 1992, she serves on a variety of local and national Committees. She is Past-Chair of the American Heart Association’s Functional Genomics and Translational Biology Council and Study Section, and the annual Heart and Stroke Statistical Update..
She received the 2015 Paul Dudley White Award, the 2016 AHA Gold Heart Award, and the 2016 Population Research Prize. She serves the AHA as Science Representative to the National Board of Directors and Chairs of the Science and Clinical Education Lifelong Learning Committee.
- Professor, Cardiovascular Medicine, Medicine, Boston University School of Medicine
- Professor, Epidemiology, Boston University School of Public Health
- Director, Echocardiography/Vascular Laboratory, Framingham Heart Study
- Case Western Reserve University, MD
- Harvard College, AB
- Harvard School of Public Health, SM/ScM
- 2 experiential semin
- Published on 9/3/2019
Georgakis MK, Malik R, Björkbacka H, Pana TA, Demissie S, Ayers C, Elhadad MA, Fornage M, Beiser AS, Benjamin EJ, Boekholdt MS, Engström G, Herder C, Hoogeveen RC, Koenig W, Melander O, Orho-Melander M, Schiopu A, Söderholm M, Wareham N, Ballantyne CM, Peters A, Seshadri S, Myint PK, Nilsson J, de Lemos JA, Dichgans M. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals. Circ Res. 2019 Sep 03. PMID: 31476962.
- Published on 8/9/2019
Brunner KT, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors. Clin Gastroenterol Hepatol. 2019 Aug 09. PMID: 31404666.
- Published on 8/8/2019
Conner SC, Lodi S, Lunetta KL, Casas JP, Lubitz SA, Ellinor PT, Anderson CD, Huang Q, Coleman J, White WB, Benjamin EJ, Trinquart L. Refining the Association Between Body Mass Index and Atrial Fibrillation: G-Formula and Restricted Mean Survival Times. J Am Heart Assoc. 2019 Aug 20; 8(16):e013011. PMID: 31390924.
- Published on 7/3/2019
Behnam V, Rong J, Larson MG, Gotal JD, Benjamin EJ, Hamburg NM, Vasan RS, Mitchell GF. Windkessel Measures Derived From Pressure Waveforms Only: The Framingham Heart Study. J Am Heart Assoc. 2019 Jul 16; 8(14):e012300. PMID: 31266389.
- Published on 6/19/2019
Li S, Cheng J, Cui L, Gurol ME, Bhatt DL, Fonarow GC, Benjamin EJ, Xing A, Xia Y, Wu S, Gao X. Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation. J Am Heart Assoc. 2019 Jul 02; 8(13):e012020. PMID: 31213103.
- Published on 6/6/2019
Zheng S, Lubin B, Au R, Murabito JM, Benjamin EJ, Shwartz M. Advantages of Continuous-Valued Risk Scores for Predicting Long-Term Costs: The Framingham Coronary Heart Disease 10-Year Risk Score. Adv Geriatr Med Res. 2019; 1(1). PMID: 31448373.
- Published on 5/24/2019
Wilechansky RM, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis. Liver Int. 2019 Aug; 39(8):1535-1544. PMID: 31033142.
- Published on 5/22/2019
Conner SC, Sullivan LM, Benjamin EJ, LaValley MP, Galea S, Trinquart L. Adjusted restricted mean survival times in observational studies. Stat Med. 2019 Sep 10; 38(20):3832-3860. PMID: 31119770.
- Published on 5/16/2019
Di Frances CD, Childs E, Fetterman JL, Villanti AC, Stanton CA, Russo AR, Hirsch GA, Solis AC, Benjamin EJ. Implementing and Evaluating a Mentor Training to Improve Support for Early-Career Scholars in Tobacco Regulatory Science. Nicotine Tob Res. 2019 May 16. PMID: 31095330.
- Published on 5/7/2019
Andersson C, Johnson AD, Benjamin EJ, Levy D, Vasan RS. 70-year legacy of the Framingham Heart Study. Nat Rev Cardiol. 2019 May 07. PMID: 31065045.
View 677 more publications: View full profile at BUMC